|
Index of reports
> Cases with Nausea (195)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 195 Next >>
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient:
Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Rebetol
Dosage: unk
Administration route: Oral
Victrelis
Dosage: unk
Administration route: Oral
Other drugs received by patient: Protonix
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Fatigue, Nausea, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Rebetol
Administration route: Oral
Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25
Patient:
Reactions: Nausea, Flatulence
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-27
Possible PEG-Intron side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 67 year old female
Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.94 a?g/kg, unk
Start date: 2012-04-06
End date: 2012-04-26
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-03-30
PEG-Intron
Dosage: 1.13 a?g/kg, unk
Start date: 2012-04-27
End date: 2012-05-10
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-05-11
End date: 2012-08-02
PEG-Intron
Dosage: 1.5 a?g/kg, unk
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-03-29
PEG-Intron
Start date: 2012-05-11
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-04-19
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-08-02
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
VX-950
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-04-13
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-22
VX-950
Dosage: 2250 mg, qd
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient:
Reactions: Fatigue, Sleep Disorder, Nausea, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-07-19
Ribasphere
Dosage: unk
Start date: 2012-07-19
Victrelis
Dosage: 800 mg/tid
Administration route: Oral
Indication: Hepatitis C
Possible PEG-Intron side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 54 year old female
Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-28
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-06-12
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-19
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-20
End date: 2012-07-31
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-22
End date: 2012-05-08
Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: Myalgia, Diarrhoea, Nausea, Chills
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Ribavirin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-11
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-05-31
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-01
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-06
Other drugs received by patient: Loxonin; Antebate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: Abdominal Pain, Oral Mucosal Blistering, Vomiting, LIP Blister, Nausea, Muscle Spasms
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Start date: 2012-08-17
End date: 2012-08-19
Rebetol
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
Incivek
Dosage: 2 df, q8h
Administration route: Oral
PEG-Intron
Rebetol
Administration route: Oral
Other drugs received by patient: Lorazepam; Ferrous Sulfate TAB; Levothyroxine Sodium; Tylenol
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Telaprevir
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Valtrex
Dosage: unk unk, unknown
Indication: Herpes Zoster
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-01
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Nausea, Product Taste Abnormal
Drug(s) suspected as cause:
PEG-Intron
Rebetol
Dosage: unk
Administration route: Oral
Victrelis
Dosage: 4 df, tid
Administration route: Oral
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Nausea, RED Blood Cell Count Decreased, Asthenia, Somnolence
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-23
Rebetol
Dosage: 200 mg, bid
Administration route: Oral
Rebetol
Dosage: 400 mg,
Indication: Hepatitis C
Start date: 2012-02-23
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-03-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-09-08
End date: 2012-08-09
Ribavirin
Dosage: unk unk, unknown
Start date: 2011-09-08
End date: 2012-08-09
Other drugs received by patient: Telaprevir
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-04-13
PEG-Intron
Dosage: 0.4 ml, unk
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Nausea, Decreased Appetite
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-03-29
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-30
End date: 2012-04-16
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-04-16
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-04-16
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-03-29
Telavic
Administration route: Oral
Start date: 2012-03-30
End date: 2012-04-16
Other drugs received by patient: Levocarnitine Hydrochloride; Rabeprazole Sodium; Primperan TAB; L Cartin; Rebamipide
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-23
Patient:
Reactions: Nausea, Erythema, Neutrophil Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-24
Rebetol
Dosage: 800 mg, qd,cumulative dose:3200 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-24
End date: 2012-02-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-27
End date: 2012-06-03
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-03-02
End date: 2012-03-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-24
End date: 2012-02-28
Other drugs received by patient: Antebate; Loxonin; Valsartan; Lasix; Amino Acids (Unspecified); Norvasc; Lansoprazole; Allegra; Petrolatum; Aspirin; Humalog; Doxazosin Mesylate
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Nausea, Pyrexia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Start date: 2012-07-01
Ribasphere
Ribavirin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Contusion, Head Discomfort, Somnolence, Fall, Abdominal Pain Upper, Loss of Consciousness, Fatigue, Dizziness, Blood Creatinine Increased, Migraine, Back Pain, Nausea, Hypotension, Convulsion, Eye Pain, Tremor
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-09
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-07
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Oesophageal Pain, Nausea, Pain, Rash
Drug(s) suspected as cause:
PEG-Intron
Ribavirin
Victrelis
Dosage: 800 mg, tid every 7-9 hours
Start date: 2012-02-01
Other drugs received by patient: Carafate; Ondansetron; Lorazepam; Aciphex; Cyanocobalamin; Advil
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-22
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-02-29
End date: 2012-02-29
PEG-Intron
Dosage: 0mcg/kg
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-14
Rebetol
Administration route: Oral
Start date: 2012-02-15
End date: 2012-03-07
Rebetol
Administration route: Oral
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-07
Telavic
Administration route: Oral
Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-21
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-06-17
Rebetol
Administration route: Oral
Start date: 2012-06-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-06-24
Telavic
Administration route: Oral
Start date: 2012-06-25
Other drugs received by patient: Voltaren; Mucosta
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-22
Patient:
Reactions: Vomiting, Renal Disorder, Nausea
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-17
Investigational Drug (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-01
Investigational Drug (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-27
End date: 2012-04-03
Investigational Drug (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-04-04
PEG-Intron
Dosage: 1.3mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-28
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-02-24
End date: 2012-02-24
Peginterferon Alfa-2B
Dosage: 80 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-23
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-17
Rebetol
Administration route: Oral
Start date: 2012-02-24
End date: 2012-02-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-01
Telavic
Administration route: Oral
Start date: 2012-02-24
End date: 2012-02-26
Telavic
Administration route: Oral
Start date: 2012-03-27
End date: 2012-04-03
Telavic
Administration route: Oral
Start date: 2012-04-04
Telavic
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-17
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-28
End date: 2012-03-01
Other drugs received by patient: Warfarin Sodium; Urso 250; Digoxin; Urso 250; Nizatidine; Efonidipine Hydrochloride Ethanolate; Nizatidine; Diovan
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-22
Patient:
Reactions: Confusional State, Dyspnoea, Nausea, Anaemia, Rectal Haemorrhage, DRY Skin, Amnesia, Fatigue, Diarrhoea, DRY Mouth, Alopecia, Anorectal Discomfort, Depressed Mood, Injection Site Exfoliation, Aphonia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 microgram, qw, per injection
Rebetol
Dosage: unk
Other drugs received by patient: Tricor; Micardis; Omega-3-Acid Ethyl Esters; Wellbutrin; Cardura; Vitamin E; Glucosamine
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Nausea, Brain Abscess, Blood Uric Acid Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-16
End date: 2012-02-23
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-16
PEG-Intron
Dosage: 80 mcg/week
Start date: 2012-01-16
End date: 2012-05-07
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-02-27
End date: 2012-03-08
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-16
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-04-16
End date: 2012-04-22
Rebetol
Dosage: 200 mg/2 days
Administration route: Oral
Start date: 2012-03-09
End date: 2012-04-14
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-01-16
End date: 2012-02-26
Rebetol
Dosage: 400 mg/2 days
Administration route: Oral
Start date: 2012-03-10
End date: 2012-04-15
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-13
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-16
End date: 2012-02-23
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-02-24
End date: 2012-04-09
Other drugs received by patient: Carvedilol; Allegra; Carvedilol; Allegra; Diovan; Diovan; Naqua; [therapy Unspecified]; Trichlormethiazide
Page 1 Next >>
|
